Progression of early urine markers in diabetic nephropathy
10.3760/cma.j.cn431274-20190408-00399
- VernacularTitle:糖尿病肾病的早期尿液标志物进展
- Author:
Hang ZHANG
1
;
Wenwen ZHENG
;
Xinhe ZHOU
;
Chenwei WU
;
Chao ZHENG
Author Information
1. 温州医科大学附属第二医院内分泌科 325000
- From:
Journal of Chinese Physician
2020;22(6):949-952
- CountryChina
- Language:Chinese
-
Abstract:
Diabetic nephropathy (DN) is one of the major microvascular complications in diabetic patients, and it is also the main global cause of chronic kidney disease(CKD) and end-stage renal disease(ESRD). Albuminuria and estimated glomerular filtration rate (eGFR) are currently recognized as clinically diagnosed early DN, but their sensitivity and specificity are poor. Therefore, it is very important to find new biomarkers to reflect the potential diabetic nephropathy in the clinical silent period.
